By 2026, the global CRRT industry is expected to reach USD 1.7 billion, with a compound annual growth rate of 7.3% in 2021 – QNT Press Release

[ad_1]

Dublin, July 5, 2021 (Global News Service) – “By product (disposable products (blood filter, blood line), machine, dialysate, kidney replacement fluid), form (SCUF, CVVH, CVVHD, CVVHDF), patient (adult, pediatric, newborn) and region-to Forecast for 2026” Report has been added to ResearchAndMarkets.com provide.

The global continuous renal replacement therapy market is expected to grow from USD 1.2 billion in 2021 to USD 1.7 billion in 2026, with a compound annual growth rate of 7.3% during the forecast period.

The dialysate and replacement fluid parts will occupy the largest share of the continuous renal replacement therapy market by product during the forecast period

The dialysate and replacement fluid parts are expected to achieve the highest growth rate during the forecast period. Its high growth is attributed to the significant increase in the demand for CRRT in the treatment of patients with hemodynamic instability, the increase in the number of manufacturers that provide dialysate and replacement fluids for renal replacement therapy, and the strong presence of market participants.

The CVVHDF market segment will witness the highest growth rate of the continuous renal replacement therapy market in 2021 according to the model

The modal part of CVVHDF is expected to witness the highest growth rate during the forecast period. Nephrologists and intensive care doctors increasingly prefer the CVVHDF mode, and compared with hemodialysis, the clearance of medium-sized solutes is better (due to the combination of hemofiltration and continuous HD procedures), proper acid-base balance is not required Additional interventions, as well as a significant reduction in the area of ​​phosphate consumption associated with CRRT, may play an important role in supporting the growth of this market segment in the coming years.

In 2021, by age group, the adult portion will have the largest share of continuous renal replacement therapy

The rapid increase in adult acute kidney disease injury cases worldwide and the increase in the number of young people hospitalized are playing a key role…

The full story on Benzinga.com

[ad_2]

Source link